Swissmedic Issues DHPC for DIBASE® 10’000 to Address Handling Errors
On November 22, 2025, Swissmedic released a Direct Healthcare Professional Communication (DHPC) concerning DIBASE® 10’000 (cholecalciferolum). This announcement highlights crucial…
Europe
europe updates on medical device regulation and quality.
258 articles
258 articles in Europe
Latest News
Latest News
Precautionary Recall of Fingolimod SUN 0.5mg by Sun Pharma: Capsule Breakage Risk Emerges
Sun Pharma UK Limited has issued a precautionary recall for one batch of Fingolimod SUN 0.5 mg hard capsules. This…
Latest News
Feedback Requested: Consultation on SaMD ‘Predetermined Change Control Plans’ Closing December 2025
The Software as a Medical Device (SaMD) Working Group has invited stakeholders to review and comment on the draft document…
Latest News
Temporary Approval Issued for Selectol 200 mg Tablets in French Packaging
Swissmedic has issued a temporary authorization allowing the distribution of Selectol 200 mg film-coated tablets in French-language packaging. This regulatory…
Latest News
Swissmedic Updates: New Measures to Address Suicide Risk with Finasteride and Dutasteride
On November 18, 2025, Swissmedic announced new measures to mitigate the risk of suicidal thoughts associated with the use of…
Latest News
Swissmedic’s Multilingual Initiative: Vigilance-News Now Available in Four Languages
Swissmedic has announced an important update to its Vigilance-News publication, ensuring accessibility for a broader audience. Starting with Edition 35,…
Latest News
Swissmedic Releases Haemovigilance Annual Report 2024 With Key Findings on Transfusion Safety
Swissmedic, the Swiss agency for therapeutic products, has published its Haemovigilance Annual Report for the year 2024. The report evaluates…
Latest News
Swissmedic Issues Recall for GlucoSaline B. Braun Infusion Solution Batch
Swissmedic has announced a recall of batch number 242867651 for the product GlucoSaline B. Braun Infusion Solution. This action affects…
Latest News
Swissmedic Updates: Safety Revisions to Product Information Starting November 2025
Swissmedic has announced a significant update regarding the publication of safety-related revisions to product information. Effective November 2025, clinicians, regulatory…
Latest News
Swissmedic Announces Initial Authorisation of ZYNYZ® – Key Updates for Industry Professionals
Swissmedic has granted the first authorisation for ZYNYZ®, marking a significant regulatory milestone. This development signals an important step for…
Latest News
Swissmedic Grants First Authorization for DATROWAY®: A Regulatory Milestone
On November 14, 2025, Swissmedic officially announced the first authorization of DATROWAY®, marking an important step in regulatory approvals for…
Latest News
Swissmedic Grants First Authorization for Pylclari®: Key Updates for Regulatory Teams
On November 14, 2025, Swissmedic officially announced the first regulatory authorization of Pylclari®, marking an important step in medical device…
Loading more articles…